The Lancet Haematology
The global community of researchers and clinicians working in the research and treatment of haematological disease needs a source of information that is authoritative, evidence-based, and clinically relevant. The Lancet Haematology will become that source, with practice-changing research articles, expert commentary, and provocative opinion in an online-only format. The topics in this journal will be broad, reflecting the breadth of the subject matter, focusing on research that advocates change in, or illuminates, haematological clinical practice. This will include haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, transfusion medicine, and related conditions and diseases. Although there have been great leaps towards in haematological research and patient care, there is still much work to be done, and we hope you will join us in delivering better health.

Global Print Circulation
5,000Avg. Global Monthly Visits
55,209Avg. Global Monthly Unique Visitors
21,840Avg. Global Monthly Page Views
31,287Avg. Global eTOC Distribution
42,671Contacts
Display Advertising
-
Bill Hipple United States
646-671-0385
b.hipple@elsevier.com -
Robert Bayliss Europe
44 20 7424 4454
r.bayliss@elsevier.com -
Virginia Van Homrigh APAC
61 448 008159
v.vanhomrigh@elsevier.com -
Derek Zakaib Canada
514-730-8837
derekjohnzakaib@gmail.com
Recruitment Advertising
-
Philip Prigal Global
347-556-0473
p.prigal@elsevier.com
Have a question or need assistance?
Contact us now and a Sales Representative will be in touch.